Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

106.15 -0.23 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,133,196
Open 106.11
Bid (Size) 102.65 (1)
Ask (Size) 102.99 (1)
Prev. Close 106.38
Today's Range 105.74 - 107.56
52wk Range 62.07 - 119.96
Shares Outstanding 1,253,809,440
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which S&P500 stocks are moving after the closing bell on Thursday?
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session. 
Via Chartmill
Gilead (GILD) Q1 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
Exposures Financial Product Safety Tariff

Performance

YTD
+15.5%
+15.5%
1 Month
-1.6%
-1.6%
3 Month
+14.2%
+14.2%
6 Month
+19.6%
+19.6%
1 Year
+58.2%
+58.2%

More News

Read More
Gilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS Guidance
Via Benzinga
Gilead Sciences (NASDAQ:GILD) Misses Q1 Revenue Estimates
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Earnings Scheduled For April 24, 2025
Via Benzinga
P/E Ratio Insights for Gilead Sciences
Via Benzinga
Gilead Sciences' Bread-And-Butter Drug Missed Sales Views. And It's Not The Only One.
Via Investor's Business Daily
Exposures COVID-19
Gilead Sciences Announces First Quarter 2025 Financial Results
From Gilead Sciences, Inc.
Via Business Wire
Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher
Via Benzinga
Gilead Sciences's Options Frenzy: What You Need to Know
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Exploring Gilead Sciences's Earnings Expectations
Via Benzinga
Gilead Sciences (GILD) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Assessing Gilead Sciences: Insights From 15 Financial Analysts
Via Benzinga
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
Via Benzinga
Gilead Announces Positive Results From Trodelvy-Keytruda Combo Study For Breast Cancer: But Retail’s Unmoved
Via Stocktwits
Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer
From Gilead Sciences, Inc.
Via Business Wire
Why Quality Investors May Find GILEAD SCIENCES INC (NASDAQ:GILD) Attractive.
Via Chartmill
2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around
Via The Motley Fool
Topics ETFs Economy World Trade
Exposures Economy Tariff
Time 100 Most Influential People Includes Elon Musk, Mark Zuckerberg, Alex Karp And More Public Company CEOs
Via Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Via Benzinga
Topics Government
Exposures Political
3 Reasons GILD is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Is Iovance Biotherapeutics a Millionaire-Maker?
Via The Motley Fool
Exposures Product Safety
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025
From Gilead Sciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 106.15
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 04/24/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 133.09B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 133B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.